Farnham Fireworks - farnhamfireworks.com
Guildford Fireworks Festival - www.guildfordlions.com/firework-fes...
The Hills Fireworks, Hindhead - www.eventcreate.com/e/thehillsfi...
5/5
Guildford Fireworks Festival - www.guildfordlions.com/firework-fes...
The Hills Fireworks, Hindhead - www.eventcreate.com/e/thehillsfi...
5/5
October 24, 2026 at 1:58 PM
Farnham Fireworks - farnhamfireworks.com
Guildford Fireworks Festival - www.guildfordlions.com/firework-fes...
The Hills Fireworks, Hindhead - www.eventcreate.com/e/thehillsfi...
5/5
Guildford Fireworks Festival - www.guildfordlions.com/firework-fes...
The Hills Fireworks, Hindhead - www.eventcreate.com/e/thehillsfi...
5/5
PCCTC SOC Chair and PCWG4 Co-Lead Author @mjmorrismd.bsky.social discusses Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4 with @oncoalert.bsky.social www.linkedin.com/feed/update/...
#gu26 #prostatecancer | OncoAlert
Just Published at JCO & POSTER NOW BEING PRESENTED 11:30-12:45pm
ABSTRACT 162 Poster Bd E17 ( ⭐ Please Visit ⭐ ) American Society of Clinical Oncology (ASCO) #GU26
Trial Design and Objectives for P...
www.linkedin.com
February 27, 2026 at 1:10 AM
PCCTC SOC Chair and PCWG4 Co-Lead Author @mjmorrismd.bsky.social discusses Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4 with @oncoalert.bsky.social www.linkedin.com/feed/update/...
PCCTC investigator and PCWG4 co-lead author Dr Andrew J. Armstrong discusses the new prostate cancer trial design recommendations with OncoAlert: www.linkedin.com/feed/update/...
#gu26 #prostatecancer | OncoAlert
Just Published at JCO and out for #GU26
Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4
https://lnkd.in/dqfJFynp
Here is Dr An...
www.linkedin.com
February 26, 2026 at 8:01 PM
PCCTC investigator and PCWG4 co-lead author Dr Andrew J. Armstrong discusses the new prostate cancer trial design recommendations with OncoAlert: www.linkedin.com/feed/update/...
We’re excited to highlight the groundbreaking research being shared tomorrow by PCCTC investigators at #GU26! From cutting-edge clinical trial results to revised PCWG4 guidelines, these abstracts showcase the passion and progress driving the future of prostate cancer care.
February 25, 2026 at 9:17 PM
We’re excited to highlight the groundbreaking research being shared tomorrow by PCCTC investigators at #GU26! From cutting-edge clinical trial results to revised PCWG4 guidelines, these abstracts showcase the passion and progress driving the future of prostate cancer care.
K36 Therapeutics Highlights PCCTC-managed First-in-Human KTX-2001 Prostate Cancer Study Design at #GU26 www.prnewswire.com/news-release...
K36 Therapeutics Highlights First-in-Human KTX-2001 Prostate Cancer Study Design at American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2026
/PRNewswire/ -- K36 Therapeutics, Inc. ("K36"), a privately held, clinical-stage biotechnology company developing novel targeted therapies for cancers with...
www.prnewswire.com
February 24, 2026 at 8:13 PM
K36 Therapeutics Highlights PCCTC-managed First-in-Human KTX-2001 Prostate Cancer Study Design at #GU26 www.prnewswire.com/news-release...
PCCTC Investigator Dr. Maha Hussain to Present BRCAAway Prostate Cancer Trial Results at #GU26 Showing Median Survival Exceeding 5 Years with Abiraterone Plus Olaparib www.pcctc.org/news/landmar...
Landmark Prostate Cancer Trial Shows Combination Therapy More Than Doubles Survival in Metastatic Castration Resistant Prostate Cancer Patients with DNA Repair Defects — The PCCTC
PCCTC Investigator Dr. Maha Hussain to Present BRCAAway Trial Results Showing Median Survival Exceeding 5 Years with Abiraterone Plus Olaparib at 2026 ASCO GU Symposium CHICAGO, IL – The Prostate...
www.pcctc.org
February 24, 2026 at 1:11 PM
PCCTC Investigator Dr. Maha Hussain to Present BRCAAway Prostate Cancer Trial Results at #GU26 Showing Median Survival Exceeding 5 Years with Abiraterone Plus Olaparib www.pcctc.org/news/landmar...
We are pleased to announce the first public presentation of updated global standards for advanced prostate cancer clinical trials, Prostate Cancer Working Group 4 (PCWG4), at #GU26: www.pcctc.org/news/prostat...
Prostate Cancer Working Group 4 Unveils Updated Global Standards for Advanced Prostate Cancer Clinical Trials at 2026 ASCO GU Symposium — The PCCTC
The Prostate Cancer Clinical Trials Consortium today presented the Prostate Cancer Working Group 4 (PCWG4) clinical trials guidelines at the 2026 American Society for Clinical Oncology Genitourinary ...
www.pcctc.org
February 23, 2026 at 10:05 PM
We are pleased to announce the first public presentation of updated global standards for advanced prostate cancer clinical trials, Prostate Cancer Working Group 4 (PCWG4), at #GU26: www.pcctc.org/news/prostat...
PCCTC Investigators To Showcase Groundbreaking Prostate Cancer Research at 2026 ASCO GU Symposium (#GU26): www.pcctc.org/news/pcctc-i...
PCCTC Investigators Showcase Groundbreaking Research at 2026 ASCO GU Symposium — The PCCTC
Multiple Abstracts Highlight The PCCTC's Leadership in Advancing Prostate Cancer Clinical Trials and Treatment Standards The Prostate Cancer Clinical Trials Consortium (PCCTC) today announced that ...
www.pcctc.org
February 20, 2026 at 1:10 PM
PCCTC Investigators To Showcase Groundbreaking Prostate Cancer Research at 2026 ASCO GU Symposium (#GU26): www.pcctc.org/news/pcctc-i...
Our Coverage from #GU26 Continues
We are proud to have Dr. Clara Steiner 🇩🇪of DanaFarber 🇺🇸share with you her poster Presented in San Francisco
Pilot phase I trial of an implantable microdevice for in vivo evaluation of drug response in renal cell carcinoma.
We are proud to have Dr. Clara Steiner 🇩🇪of DanaFarber 🇺🇸share with you her poster Presented in San Francisco
Pilot phase I trial of an implantable microdevice for in vivo evaluation of drug response in renal cell carcinoma.
March 20, 2026 at 3:55 PM
Our Coverage from #GU26 Continues
We are proud to have Dr. Clara Steiner 🇩🇪of DanaFarber 🇺🇸share with you her poster Presented in San Francisco
Pilot phase I trial of an implantable microdevice for in vivo evaluation of drug response in renal cell carcinoma.
We are proud to have Dr. Clara Steiner 🇩🇪of DanaFarber 🇺🇸share with you her poster Presented in San Francisco
Pilot phase I trial of an implantable microdevice for in vivo evaluation of drug response in renal cell carcinoma.
Our friends and collaborators at High5Oncology were on the ground in San Francisco
FIND THEM HERE 👉 buff.ly/9peFwD4
Capturing THE KEY discussions from ASCO GU and highlighting the innovations shaping the future of GU oncology and THEIR #GU26 PAGE IS NOW LIVE!!
FIND THEM HERE 👉 buff.ly/9peFwD4
Capturing THE KEY discussions from ASCO GU and highlighting the innovations shaping the future of GU oncology and THEIR #GU26 PAGE IS NOW LIVE!!
March 10, 2026 at 10:15 AM
Our friends and collaborators at High5Oncology were on the ground in San Francisco
FIND THEM HERE 👉 buff.ly/9peFwD4
Capturing THE KEY discussions from ASCO GU and highlighting the innovations shaping the future of GU oncology and THEIR #GU26 PAGE IS NOW LIVE!!
FIND THEM HERE 👉 buff.ly/9peFwD4
Capturing THE KEY discussions from ASCO GU and highlighting the innovations shaping the future of GU oncology and THEIR #GU26 PAGE IS NOW LIVE!!
Our friends and collaborators at High5Oncology were on the ground in San Francisco
FIND THEM HERE 👉 buff.ly/WQZpPkz
Capturing THE KEY discussions from ASCO GU and highlighting the innovations shaping the future of GU oncology and THEIR #GU26 PAGE IS NOW LIVE!!
FIND THEM HERE 👉 buff.ly/WQZpPkz
Capturing THE KEY discussions from ASCO GU and highlighting the innovations shaping the future of GU oncology and THEIR #GU26 PAGE IS NOW LIVE!!
March 6, 2026 at 10:37 AM
Our friends and collaborators at High5Oncology were on the ground in San Francisco
FIND THEM HERE 👉 buff.ly/WQZpPkz
Capturing THE KEY discussions from ASCO GU and highlighting the innovations shaping the future of GU oncology and THEIR #GU26 PAGE IS NOW LIVE!!
FIND THEM HERE 👉 buff.ly/WQZpPkz
Capturing THE KEY discussions from ASCO GU and highlighting the innovations shaping the future of GU oncology and THEIR #GU26 PAGE IS NOW LIVE!!
Our friends and collaborators at High5Oncology were on the ground in San Francisco
FIND THEM HERE 👉 buff.ly/WQZpPkz
Capturing THE KEY discussions from ASCO GU and highlighting the innovations shaping the future of GU oncology and THEIR #GU26 PAGE IS NOW LIVE!!
FIND THEM HERE 👉 buff.ly/WQZpPkz
Capturing THE KEY discussions from ASCO GU and highlighting the innovations shaping the future of GU oncology and THEIR #GU26 PAGE IS NOW LIVE!!
March 4, 2026 at 4:33 PM
Our friends and collaborators at High5Oncology were on the ground in San Francisco
FIND THEM HERE 👉 buff.ly/WQZpPkz
Capturing THE KEY discussions from ASCO GU and highlighting the innovations shaping the future of GU oncology and THEIR #GU26 PAGE IS NOW LIVE!!
FIND THEM HERE 👉 buff.ly/WQZpPkz
Capturing THE KEY discussions from ASCO GU and highlighting the innovations shaping the future of GU oncology and THEIR #GU26 PAGE IS NOW LIVE!!
Our friends from @GuardConsortium 🇪🇸Deliver another Great Informational Capsule, this time direct from #GU26 🇺🇸
We are proud to introduce our Colleague @mjuanfi81 Discussing the Presentation of:
Pathological outcomes and disease-free survival (DFS) in KEYNOTE-905 #BladderCancer
We are proud to introduce our Colleague @mjuanfi81 Discussing the Presentation of:
Pathological outcomes and disease-free survival (DFS) in KEYNOTE-905 #BladderCancer
March 4, 2026 at 11:39 AM
Our friends from @GuardConsortium 🇪🇸Deliver another Great Informational Capsule, this time direct from #GU26 🇺🇸
We are proud to introduce our Colleague @mjuanfi81 Discussing the Presentation of:
Pathological outcomes and disease-free survival (DFS) in KEYNOTE-905 #BladderCancer
We are proud to introduce our Colleague @mjuanfi81 Discussing the Presentation of:
Pathological outcomes and disease-free survival (DFS) in KEYNOTE-905 #BladderCancer
Our friends and collaborators at High5Oncology were on the ground in San Francisco
FIND THEM HERE 👉 buff.ly/WQZpPkz
Capturing THE KEY discussions from ASCO GU and highlighting the innovations shaping the future of GU oncology and THEIR #GU26 PAGE IS NOW LIVE!!
FIND THEM HERE 👉 buff.ly/WQZpPkz
Capturing THE KEY discussions from ASCO GU and highlighting the innovations shaping the future of GU oncology and THEIR #GU26 PAGE IS NOW LIVE!!
March 2, 2026 at 5:30 PM
Our friends and collaborators at High5Oncology were on the ground in San Francisco
FIND THEM HERE 👉 buff.ly/WQZpPkz
Capturing THE KEY discussions from ASCO GU and highlighting the innovations shaping the future of GU oncology and THEIR #GU26 PAGE IS NOW LIVE!!
FIND THEM HERE 👉 buff.ly/WQZpPkz
Capturing THE KEY discussions from ASCO GU and highlighting the innovations shaping the future of GU oncology and THEIR #GU26 PAGE IS NOW LIVE!!
Dear Colleagues
A REMINDER that the OncoAlert 🚨 #GU26 Newletter is OUT Soon
REGISTER TO GET IT at buff.ly/IJBA636 or buff.ly/p4JdYes
OUR PICKS of The TOP Trials from #GU26 SAN FRANCISCO🇺🇸
ALL IN ONE PLACE!!
A REMINDER that the OncoAlert 🚨 #GU26 Newletter is OUT Soon
REGISTER TO GET IT at buff.ly/IJBA636 or buff.ly/p4JdYes
OUR PICKS of The TOP Trials from #GU26 SAN FRANCISCO🇺🇸
ALL IN ONE PLACE!!
March 2, 2026 at 3:04 PM
Dear Colleagues
A REMINDER that the OncoAlert 🚨 #GU26 Newletter is OUT Soon
REGISTER TO GET IT at buff.ly/IJBA636 or buff.ly/p4JdYes
OUR PICKS of The TOP Trials from #GU26 SAN FRANCISCO🇺🇸
ALL IN ONE PLACE!!
A REMINDER that the OncoAlert 🚨 #GU26 Newletter is OUT Soon
REGISTER TO GET IT at buff.ly/IJBA636 or buff.ly/p4JdYes
OUR PICKS of The TOP Trials from #GU26 SAN FRANCISCO🇺🇸
ALL IN ONE PLACE!!
Dear Colleagues
A REMINDER that the OncoAlert 🚨 #GU26 Newletter is OUT Soon
REGISTER TO GET IT at buff.ly/IJBA636 or www.OncoAlert360.com
OUR PICKS of The TOP Trials from #GU26 SAN FRANCISCO🇺🇸
ALL IN ONE PLACE!!
A REMINDER that the OncoAlert 🚨 #GU26 Newletter is OUT Soon
REGISTER TO GET IT at buff.ly/IJBA636 or www.OncoAlert360.com
OUR PICKS of The TOP Trials from #GU26 SAN FRANCISCO🇺🇸
ALL IN ONE PLACE!!
February 28, 2026 at 11:09 PM
Dear Colleagues
A REMINDER that the OncoAlert 🚨 #GU26 Newletter is OUT Soon
REGISTER TO GET IT at buff.ly/IJBA636 or www.OncoAlert360.com
OUR PICKS of The TOP Trials from #GU26 SAN FRANCISCO🇺🇸
ALL IN ONE PLACE!!
A REMINDER that the OncoAlert 🚨 #GU26 Newletter is OUT Soon
REGISTER TO GET IT at buff.ly/IJBA636 or www.OncoAlert360.com
OUR PICKS of The TOP Trials from #GU26 SAN FRANCISCO🇺🇸
ALL IN ONE PLACE!!
OUR GRATITUDE to the MOST amazing Hosts, our friends at @ASCO !
A Wonderful meeting full of Science and friendship and thanks to their efforts #GU26 was A GREAT SUCCESS!! KUDOS!!! SEE YOU IN CHICAGO!!
Best,
@OncoAlert 🚨
A Wonderful meeting full of Science and friendship and thanks to their efforts #GU26 was A GREAT SUCCESS!! KUDOS!!! SEE YOU IN CHICAGO!!
Best,
@OncoAlert 🚨
February 28, 2026 at 9:49 PM
OUR GRATITUDE to the MOST amazing Hosts, our friends at @ASCO !
A Wonderful meeting full of Science and friendship and thanks to their efforts #GU26 was A GREAT SUCCESS!! KUDOS!!! SEE YOU IN CHICAGO!!
Best,
@OncoAlert 🚨
A Wonderful meeting full of Science and friendship and thanks to their efforts #GU26 was A GREAT SUCCESS!! KUDOS!!! SEE YOU IN CHICAGO!!
Best,
@OncoAlert 🚨
Dear colleagues at #GU26
Our friends and collaborators at High5Oncology were on the ground in San Francisco capturing THE KEY discussions from ASCO GU and highlighting the innovations shaping the future of GU oncology, THEIR GU26 PAGE IS SOON LIVE!
FIND THEM HERE 👉 high5oncology.tv/meeting-cove...
Our friends and collaborators at High5Oncology were on the ground in San Francisco capturing THE KEY discussions from ASCO GU and highlighting the innovations shaping the future of GU oncology, THEIR GU26 PAGE IS SOON LIVE!
FIND THEM HERE 👉 high5oncology.tv/meeting-cove...
February 28, 2026 at 9:29 PM
Dear colleagues at #GU26
Our friends and collaborators at High5Oncology were on the ground in San Francisco capturing THE KEY discussions from ASCO GU and highlighting the innovations shaping the future of GU oncology, THEIR GU26 PAGE IS SOON LIVE!
FIND THEM HERE 👉 high5oncology.tv/meeting-cove...
Our friends and collaborators at High5Oncology were on the ground in San Francisco capturing THE KEY discussions from ASCO GU and highlighting the innovations shaping the future of GU oncology, THEIR GU26 PAGE IS SOON LIVE!
FIND THEM HERE 👉 high5oncology.tv/meeting-cove...
IKCS Europe 2026🌍Transforming #KidneyCancer Research👉 buff.ly/WgG7n4V
⭐️DISCOUNTED EARLY BIRD REGISTRATION until MARCH 15th 2026⭐️
Dear Colleagues at #GU26
Join US at the International Kidney Cancer Symposium (IKCS): Europe in Paris, France🇫🇷
🗓 April 16–18, 2026
📍 Paris Marriott Rive Gauche
⭐️DISCOUNTED EARLY BIRD REGISTRATION until MARCH 15th 2026⭐️
Dear Colleagues at #GU26
Join US at the International Kidney Cancer Symposium (IKCS): Europe in Paris, France🇫🇷
🗓 April 16–18, 2026
📍 Paris Marriott Rive Gauche
February 28, 2026 at 6:30 PM
IKCS Europe 2026🌍Transforming #KidneyCancer Research👉 buff.ly/WgG7n4V
⭐️DISCOUNTED EARLY BIRD REGISTRATION until MARCH 15th 2026⭐️
Dear Colleagues at #GU26
Join US at the International Kidney Cancer Symposium (IKCS): Europe in Paris, France🇫🇷
🗓 April 16–18, 2026
📍 Paris Marriott Rive Gauche
⭐️DISCOUNTED EARLY BIRD REGISTRATION until MARCH 15th 2026⭐️
Dear Colleagues at #GU26
Join US at the International Kidney Cancer Symposium (IKCS): Europe in Paris, France🇫🇷
🗓 April 16–18, 2026
📍 Paris Marriott Rive Gauche
The #OncoAlertColloquium 2026 GU Malignancies🚨 DAY3️⃣ #GU26
Presentation by Dr. Salvatore La Rosa 🇺🇸 of Kidney Cancer Association: Year in Review
REGISTER HERE TO WATCH: buff.ly/FaS5Cb6
#KidneyCancer remains a highly unmet need, especially in today’s challenging funding environment
Presentation by Dr. Salvatore La Rosa 🇺🇸 of Kidney Cancer Association: Year in Review
REGISTER HERE TO WATCH: buff.ly/FaS5Cb6
#KidneyCancer remains a highly unmet need, especially in today’s challenging funding environment
February 28, 2026 at 6:15 PM
The #OncoAlertColloquium 2026 GU Malignancies🚨 DAY3️⃣ #GU26
Presentation by Dr. Salvatore La Rosa 🇺🇸 of Kidney Cancer Association: Year in Review
REGISTER HERE TO WATCH: buff.ly/FaS5Cb6
#KidneyCancer remains a highly unmet need, especially in today’s challenging funding environment
Presentation by Dr. Salvatore La Rosa 🇺🇸 of Kidney Cancer Association: Year in Review
REGISTER HERE TO WATCH: buff.ly/FaS5Cb6
#KidneyCancer remains a highly unmet need, especially in today’s challenging funding environment
The #OncoAlertColloquium 2026 GU Malignancies🚨 DAY3️⃣ #GU26
Presentation by Dr. Brian Rini: Year in Review in Renal Cell Carcinoma #KidneyCancer
REGISTER HERE TO WATCH: buff.ly/pKfMiwK
Brian Rini’s 2025 year-in-review highlights real progress—and ongoing challenges—in kidney cancer
Presentation by Dr. Brian Rini: Year in Review in Renal Cell Carcinoma #KidneyCancer
REGISTER HERE TO WATCH: buff.ly/pKfMiwK
Brian Rini’s 2025 year-in-review highlights real progress—and ongoing challenges—in kidney cancer
February 28, 2026 at 2:30 PM
The #OncoAlertColloquium 2026 GU Malignancies🚨 DAY3️⃣ #GU26
Presentation by Dr. Brian Rini: Year in Review in Renal Cell Carcinoma #KidneyCancer
REGISTER HERE TO WATCH: buff.ly/pKfMiwK
Brian Rini’s 2025 year-in-review highlights real progress—and ongoing challenges—in kidney cancer
Presentation by Dr. Brian Rini: Year in Review in Renal Cell Carcinoma #KidneyCancer
REGISTER HERE TO WATCH: buff.ly/pKfMiwK
Brian Rini’s 2025 year-in-review highlights real progress—and ongoing challenges—in kidney cancer
The #OncoAlertColloquium 2026 GU Malignancies🚨 DAY 3️⃣ #GU26
Presentation by Dr. Brian Rini: Year in Review in Renal Cell Carcinoma #KidneyCancer
REGISTER HERE TO WATCH: buff.ly/FaS5Cb6
Brian Rini’s 2025 year-in-review highlights real progress—and ongoing challenges—in kidney cancer
Presentation by Dr. Brian Rini: Year in Review in Renal Cell Carcinoma #KidneyCancer
REGISTER HERE TO WATCH: buff.ly/FaS5Cb6
Brian Rini’s 2025 year-in-review highlights real progress—and ongoing challenges—in kidney cancer
February 28, 2026 at 2:00 PM
The #OncoAlertColloquium 2026 GU Malignancies🚨 DAY 3️⃣ #GU26
Presentation by Dr. Brian Rini: Year in Review in Renal Cell Carcinoma #KidneyCancer
REGISTER HERE TO WATCH: buff.ly/FaS5Cb6
Brian Rini’s 2025 year-in-review highlights real progress—and ongoing challenges—in kidney cancer
Presentation by Dr. Brian Rini: Year in Review in Renal Cell Carcinoma #KidneyCancer
REGISTER HERE TO WATCH: buff.ly/FaS5Cb6
Brian Rini’s 2025 year-in-review highlights real progress—and ongoing challenges—in kidney cancer
Dear Colleagues at #GU26
OncoAlert🚨 is a proud Partner of @AUC3_Official
Their Publication is NOW OUT ARTICLE HERE: 👉 acsjournals.onlinelibrary.wiley.com/doi/10.3322/...
3⃣Weeks ago We were in Sunny Miami🌴Learning from the TOP oncologists in #KidneyCancer and #BladderPractice .
OncoAlert🚨 is a proud Partner of @AUC3_Official
Their Publication is NOW OUT ARTICLE HERE: 👉 acsjournals.onlinelibrary.wiley.com/doi/10.3322/...
3⃣Weeks ago We were in Sunny Miami🌴Learning from the TOP oncologists in #KidneyCancer and #BladderPractice .
February 27, 2026 at 7:01 PM
Dear Colleagues at #GU26
OncoAlert🚨 is a proud Partner of @AUC3_Official
Their Publication is NOW OUT ARTICLE HERE: 👉 acsjournals.onlinelibrary.wiley.com/doi/10.3322/...
3⃣Weeks ago We were in Sunny Miami🌴Learning from the TOP oncologists in #KidneyCancer and #BladderPractice .
OncoAlert🚨 is a proud Partner of @AUC3_Official
Their Publication is NOW OUT ARTICLE HERE: 👉 acsjournals.onlinelibrary.wiley.com/doi/10.3322/...
3⃣Weeks ago We were in Sunny Miami🌴Learning from the TOP oncologists in #KidneyCancer and #BladderPractice .
The #OncoAlertColloquium 2026 GU Malignancies🚨 DAY 2 #GU26
Presentation by Dr. Silke Gillessen 🇨🇭 of APCCC: Year in Review #ProstateCancer
REGISTER HERE TO WATCH: buff.ly/FaS5Cb6
Presentation by Dr. Silke Gillessen 🇨🇭 of APCCC: Year in Review #ProstateCancer
REGISTER HERE TO WATCH: buff.ly/FaS5Cb6
February 27, 2026 at 5:02 PM
The #OncoAlertColloquium 2026 GU Malignancies🚨 DAY 2 #GU26
Presentation by Dr. Silke Gillessen 🇨🇭 of APCCC: Year in Review #ProstateCancer
REGISTER HERE TO WATCH: buff.ly/FaS5Cb6
Presentation by Dr. Silke Gillessen 🇨🇭 of APCCC: Year in Review #ProstateCancer
REGISTER HERE TO WATCH: buff.ly/FaS5Cb6